ECBK

Revenue: US$6.90m (up 15% from 2Q 2024). Net income: US$1.44m (up 82% from 2Q 2024). Profit margin: 21% (up from 13% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.18 (up from US$0.096 in 2Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period ECB Bancorp's share price is broadly unchanged from a week ago. Just as investors must consider earnings, it is also important to take into account the strength of a company's balance sheet. We've done some analysis and you can see our take on ECB Bancorp's balance sheet. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Revenue: US$6.93m (up 14% from 1Q 2024). Net income: US$1.30m (up 109% from 1Q 2024). Profit margin: 19% (up from 10% in 1Q 2024). The increase in margin was driven by higher revenue. EPS: US$0.16 (up from US$0.075 in 1Q 2024). AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. All figures shown in the chart above are for the trailing 12 month (TTM) period ECB Bancorp shares are up 2.7% from a week ago. While earnings are important, another area to consider is the balance sheet. See our latest analysis on ECB Bancorp's balance sheet health. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.